Moving Forward with Decentralized Clinical Trials (DCTs) - November 9, 14, & 16, 2023

Don’t miss this opportunity to learn the important considerations for implementing decentralized clinical trials and get the key take-aways from the recently issued FDA Draft Guidance on Decentralized Clinical Trials.

Back to Agenda

Part 2: Study Design, Development, and Initiation

Session Chair(s)

Amy Bohn

Director, DCT Operations, DCT Strategy & Implementation

Bayer, United States

Session 6: Welcome and Recap of Part 1
Session 7: Trial Design Considerations
Session 8: Selection, Set-up, and Oversight of Partners and Suppliers in a DCT
Session 9: Safety and Risk Assessment
Session 10: Planning for the Participant Journey
Session 11: Data Privacy and Security Considerations
Session 12: Exercise, Questions and Answers